Huppert & Roth: (2003) Treating Obsessive-Compulsive Disorder with Exposure and Response Prevention. The Behavior Analyst Today, 4 (1), 66 – 70 BAO (页面存档备份,存于互联网档案馆)
William O'Donohue and Kyle E. Ferguson (2006): Evidence-Based Practice in Psychology and Behavior Analysis. The Behavior Analyst Today, 7(3) 335–347. BAO (页面存档备份,存于互联网档案馆)
Freeston M, Ladouceur R. What do patients do with their obsessive thoughts?. Behaviour Research and Therapy. 2003, 35 (4): 335–348. doi:10.1016/S0005-7967(96)00094-0.
Shin NY, Lee TY, Kim E, Kwon JS. Cognitive functioning in obsessive-compulsive disorder: a meta-analysis.. Psychological Medicine. 19 July 2013, 44: 1–10. PMID 23866289. doi:10.1017/S0033291713001803.
Çetinay Aydın P, Güleç Öyekçin D. Cognitive functions in patients with obsessive compulsive disorder. Turk psikiyatri dergisi = Turkish journal of psychiatry. 2013, 24 (4): 266–74. PMID 24310094. doi:10.5080/u7172.
Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Research. 1995, 59 (1–2): 57–64. PMID 8771221. doi:10.1016/0165-1781(95)02752-1.
Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Research. 1995, 59 (1–2): 57–64. PMID 8771221. doi:10.1016/0165-1781(95)02752-1.
>Paterson JL, Reynolds AC, Ferguson SA, Dawson D. Sleep and obsessive-compulsive disorder (OCD). Sleep Medicine Reviews. 2013, 17 (6): 465–74. PMID 23499210. doi:10.1016/j.smrv.2012.12.002.
Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, Macgillivray S. Arroll, Bruce , 编. Antidepressants versus placebo for depression in primary care. The Cochrane Database of Systematic Reviews. 2009, (3): CD007954. PMID 19588448. doi:10.1002/14651858.CD007954.
Fineberg NA, Brown A, Reghunandanan S, Pampaloni I. Evidence-based pharmacotherapy of obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology. 2012, 15 (8): 1173–91. PMID 22226028. doi:10.1017/S1461145711001829.
Komossa, K; Depping, AM; Meyer, M; Kissling, W; Leucht, S. Second-generation antipsychotics for obsessive compulsive disorder.. The Cochrane database of systematic reviews. 8 Dec 2010, (12): CD008141. PMID 21154394. doi:10.1002/14651858.CD008141.pub2.
Berrios G E. Obsessive Compulsive Disorder: Its conceptual history in France during the 19th Century. Comprehensive Psychiatry. 1989, 30: 283–95. doi:10.1016/0010-440x(89)90052-7.
Camfield DA, Sarris J, Berk M. Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence. Progress in neuro-psychopharmacology & biological psychiatry. 1 June 2011, 35 (4): 887–95. PMID 21352883. doi:10.1016/j.pnpbp.2011.02.011.
Davidson J, Bjorgvinsson T. Current and potential pharmacological treatments for obsessive-compulsive disorder. Expert Opinion on Investigational Drugs. June 2003, 12 (6): 993–1001. PMID 12783603. doi:10.1517/13543784.12.6.993.
Shin NY, Lee TY, Kim E, Kwon JS. Cognitive functioning in obsessive-compulsive disorder: a meta-analysis.. Psychological Medicine. 19 July 2013, 44: 1–10. PMID 23866289. doi:10.1017/S0033291713001803.
Çetinay Aydın P, Güleç Öyekçin D. Cognitive functions in patients with obsessive compulsive disorder. Turk psikiyatri dergisi = Turkish journal of psychiatry. 2013, 24 (4): 266–74. PMID 24310094. doi:10.5080/u7172.
Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Research. 1995, 59 (1–2): 57–64. PMID 8771221. doi:10.1016/0165-1781(95)02752-1.
Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Research. 1995, 59 (1–2): 57–64. PMID 8771221. doi:10.1016/0165-1781(95)02752-1.
Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, Macgillivray S. Arroll, Bruce , 编. Antidepressants versus placebo for depression in primary care. The Cochrane Database of Systematic Reviews. 2009, (3): CD007954. PMID 19588448. doi:10.1002/14651858.CD007954.
Fineberg NA, Brown A, Reghunandanan S, Pampaloni I. Evidence-based pharmacotherapy of obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology. 2012, 15 (8): 1173–91. PMID 22226028. doi:10.1017/S1461145711001829.
Komossa, K; Depping, AM; Meyer, M; Kissling, W; Leucht, S. Second-generation antipsychotics for obsessive compulsive disorder.. The Cochrane database of systematic reviews. 8 Dec 2010, (12): CD008141. PMID 21154394. doi:10.1002/14651858.CD008141.pub2.
D'Alessandro TM. Factors influencing the onset of childhood obsessive compulsive disorder. Pediatr Nurs. 2009, 35 (1): 43–6. PMID 19378573.
Camfield DA, Sarris J, Berk M. Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence. Progress in neuro-psychopharmacology & biological psychiatry. 1 June 2011, 35 (4): 887–95. PMID 21352883. doi:10.1016/j.pnpbp.2011.02.011.
Davidson J, Bjorgvinsson T. Current and potential pharmacological treatments for obsessive-compulsive disorder. Expert Opinion on Investigational Drugs. June 2003, 12 (6): 993–1001. PMID 12783603. doi:10.1517/13543784.12.6.993.
Osgood-Hynes, Deborah. Thinking Bad Thoughts (PDF).互联网档案馆的存檔,存档日期2011-11-15. MGH/McLean OCD Institute, Belmont, MA, published by the OCD Foundation, Milford, CT. Retrieved on 30 December 2006.
Osgood-Hynes, Deborah. Thinking Bad Thoughts (PDF).互联网档案馆的存檔,存档日期2011-11-15. MGH/McLean OCD Institute, Belmont, MA, published by the OCD Foundation, Milford, CT. Retrieved on 30 December 2006.
Steven Phillipson I Think It Moved互联网档案馆的存檔,存档日期2008-12-18. Center for Cognitive-Behavioral Psychotherapy, OCDOnline.com. Retrieved on 14 May 2009.
William O'Donohue and Kyle E. Ferguson (2006): Evidence-Based Practice in Psychology and Behavior Analysis. The Behavior Analyst Today, 7(3) 335–347. BAO (页面存档备份,存于互联网档案馆)